This is the Neurology section of Moniz Health Intelligence — physician-written coverage of where technology, data, and evidence meet clinical Neurology practice. Articles here are reviewed against the primary literature before publication, and each one links the studies it relies on so you can check the reasoning rather than take a summary on faith.

Coverage focuses on what has actually been validated: decision-support tools with prospective evidence, monitoring technology that changes management, and the studies that temper an over-hyped claim. Where the literature is thin or the trial base is early, the article says so instead of borrowing authority from a promising abstract. New Neurology pieces are added as the evidence develops, so this section grows rather than fills.

For reviews that cut across specialties, start with the full article index or the latest pieces on the Moniz Health Intelligence front page.

Four Lists, Not a Ladder: Inside the 2026 AAN/AHS Migraine Prevention Guideline – Evidence, Numbers, and What Changes in Practice

A Comprehensive Literature Review Prepared: 26 October 2026 Subject guideline: Potrebic S, Tanveer S, Becker WJ, et al. Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society. Neurology. 2026;107(7):e214881. PMID 42673560. Companion systematic review: Pringsheim T, Smith DB, Tanveer S, et al. Neurology. 2026;107(4):e218112. PMID … Read more